President Joe Biden (AP Images)

Pres­i­dent Biden of­fers an­oth­er push on drug price sav­ings via ex­ec­u­tive or­der

Build­ing off his re­cent­ly-signed leg­is­la­tion al­low­ing Medicare to start ne­go­ti­at­ing prices in some lim­it­ed cir­cum­stances for the most ex­pen­sive phar­ma­ceu­ti­cals, Pres­i­dent Joe Biden to­day will sign an Ex­ec­u­tive Or­der di­rect­ing HHS to con­sid­er what more it can do to dri­ve down pre­scrip­tion drug costs.

Un­der the or­der, HHS will have three months to sub­mit a for­mal re­port out­lin­ing how to use its “In­no­va­tion Cen­ter,” cre­at­ed by Oba­macare, and oth­er ex­ist­ing au­thor­i­ties to low­er drug costs and pro­mote ac­cess to in­no­v­a­tive drugs for Medicare ben­e­fi­cia­ries.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.